跳到正文
原文
Nature 健康护理主题·· 5 天前AI 评分49

美国筛查相关癌症发病率长期趋势及COVID-19疫情期间变化的SEER研究

Long-term trends and COVID-19 pandemic–era changes in the incidence of cancers with established screening strategies in the United States: a population-based SEER study

AI 导读

本研究利用SEER 21个登记处数据,分析美国40岁及以上成人肺癌、结直肠癌、乳腺癌和宫颈癌在2000–2022年的发病率趋势,并评估COVID-19疫情期间偏差。

正文

Abstract

Cancer screening and prevention constitute essential components of cancer control, although their influence on population-level incidence varies across cancer types and is shaped by patterns of healthcare access and utilization. Large-scale public health emergencies can disrupt the delivery of routine preventive, diagnostic, and oncologic services. The present study examines long-term incidence trends and evaluates changes in cancer incidence patterns during the COVID-19 pandemic. Data were sourced from the Surveillance, Epidemiology, and End Results (SEER) 21 registries database. Age-adjusted incidence rates for lung and bronchus, colon and rectum, breast, and cervix uteri cancers among adults aged 40 years and older were analyzed separately from 2000 to 2022. Joinpoint regression analysis was conducted to assess long-term incidence trends. Pre-pandemic trends from 2000 to 2019 were extrapolated to estimate expected incidence rates for 2020–2022, which were compared with observed rates. Long-term incidence declined significantly for lung and bronchus (AAPC, − 1.81%), colorectal (AAPC, − 1.94%), and cervical cancers (AAPC, − 1.48%) from 2000 to 2022, whereas breast cancer incidence showed no significant overall change (AAPC, − 0.32%). Descriptive subgroup analyses demonstrated heterogeneous patterns across age, sex, race/ethnicity, and stage. Stage distribution among diagnosed cases showed only modest year-to-year variation across the four cancer sites. Over the past two decades, lung and bronchus, colorectal, and cervical cancer incidence declined, whereas breast cancer incidence remained relatively stable among adults aged ≥ 40 years. During 2020–2022, observed incidence rates for several cancer types deviated from those expected based on pre-pandemic trends, with the largest reductions generally observed in 2020 and variable patterns thereafter. These findings highlight the importance of maintaining accessible and resilient cancer screening and diagnostic services during future public health emergencies to minimize potential disruptions in timely cancer detection and care.

Abbreviations

SEER:

Surveillance, Epidemiology, and End Results

APC:

Annual per cent change

AAPC:

Average annual per cent change

CI:

Confidence interval

NHB:

Non-Hispanic Black

NHW:

Non-Hispanic White

NHAPI:

Non-Hispanic Asian or Pacific Islander

NHAIAN:

Non-Hispanic American Indian/Alaska Nativ

Acknowledgements

The authors have nothing to report.

Funding

The authors declare no source of funding for this manuscript from any organization or any institution.

Author information

Authors and Affiliations

  1. Faculty of medicine, Al-Quds University, Jerusalem, Palestine

    Bahaa Mali, Ali Mali, Alaa Mali & Afnan W. M. Jobran

  2. Internal medicine department, The Islamic Hospital, Amman, Jordan

    Bahaa Mali

  3. Internal medicine department, Makassed Islamic Charitable hospital, Jerusalem, Palestine

    Ali Mali

  4. Ministry of Health, Ramallah, Palestine

    Alaa Mali

  5. Faculty of Medicine, University of Aleppo, Aleppo, Syria

    Mohammed Abdulrazzak

Authors

  1. Bahaa Mali
  2. Ali Mali
  3. Alaa Mali
  4. Mohammed Abdulrazzak
  5. Afnan W. M. Jobran

Corresponding author

Correspondence to Mohammed Abdulrazzak.

Ethics declarations

Ethics approval and consent to participate

This study was conducted using anonymized data obtained from the publicly available Surveillance, Epidemiology, and End Results (SEER) database. As the SEER database contains de-identified patient information, ethical approval was not required, and informed consent to participate was waived in accordance with institutional and national research ethics guidelines.

Competing interests

The authors declare no competing interests.

Consent

The data used in this research has been obtained from a publicly available dataset and does not contain any personally identifiable information.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mali, B., Mali, A., Mali, A. et al. Long-term trends and COVID-19 pandemic–era changes in the incidence of cancers with established screening strategies in the United States: a population-based SEER study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-77995-4

Download citation

  • Received: 05 August 2026

  • Accepted: 23 October 2026

  • Published: 15 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-77995-4

Keywords

来源:Nature 健康护理主题 · nature.com